WFH Clinical Research Grant Program

Grant recipients

The grant program was launched in April 2013. Through the Clinical Research Grants Program, the WFH is looking to support research that leads to improvements in outcomes and clinical care for people with bleeding disorders around the world.

Congratulations to our grant recipients!

    Ruchika Goel
    New York Presbyterian Hospital, Weill Cornell Medicine, New York, USA

    Identification of Age Varying Co-Morbidities and Predictors of Mortality in Persons with Hemophilia A and B and Derivation of a Mortality Risk Prediction Score

    Maria Eulalia Landro
    Hospital General de Agudos Dr. Juan A. Fernández, Buenos Aires, Argentina

    Platelet Rich Plasma for synovitis treatment in Patients with Haemophilia (PWH)

    Silvia Spena
    Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy

    Non Invasive Prenatal Diagnosis of hemophilia in male fetal cells circulating in the maternal blood

    Karin P.M. van Galen
    University Medical Center Utrecht, Utrecht, the Netherlands

    Pregnancy and inherited bleeding disorders, the PRIDE study

    Arijit Biswas
    Institute of Experimental Haematology and Transfusion Medicine, Bonn, Germany

    Determining the prevalence of mild heterozygous Factor XIII deficiency in the German Caucasian population for its potential clinical impact

    Hervé Chambost
    Assistance Publique des Hôpitaux de Marseille, Marseille, France

    Qualitative and quantitative protein variability in vials of marketed rFVIII / pdFVIII concentrates

    Victor Jiménez-Yuste
    Hospital Universitario La Paz, Madrid, Spain

    Tailoring prophylaxis: study of trough levels by global tests and impact of physical activity

    Marzia Menegatti
    Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy

    Evaluation of thrombin generation and fibrinolysis in patients with FXI deficiency with variable bleeding patterns

    Silvia Riva
    University of Milan, Milan, Italy

    RE.CO.VERY: REsponsibility for treatment COmpliance is VERY important. A study in elderly population with hemophilia

    Jonathan C. Roberts
    Bleeding & Clotting Disorders Institute, Peoria, USA

    An ELISA-based VWF Functional Screening Assay for Discriminating the Phenotypic Variants of VWD

    Kevin Deschamps & Sébastien Lobet
    UZ-KU Leuven, Belgium

    Quantifying foot biomechanics in hemophilic children with ankle arthropathy through an integrated approach

    Thomas Hilberg & Steffen Krüger
    Bergische Universität Wuppertal, Germany

    Pain profile in people with hemophilia

    Paula James
    Queen’s University, Kingston, Ontario, Canada

    Validation of the self-bleeding assessment tool in hemophilia carriers

    Roger Schutgens & Lize van Vulpen
    University Medical Center Utrecht, Utrecht, the Netherlands

    Joint distraction in the treatment of hemophilic ankle arthropathy

Updated July 2017

The WFH Clinical Research Grant Program was supported by funding from: